Cargando…

p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration

While the consequences of nuclear DNA damage have been well studied, the exact consequences of acute and selective mitochondrial DNA (mtDNA) damage are less understood. DNA damaging chemotherapeutic drugs are known to activate p53-dependent apoptosis in response to sustained nuclear DNA damage. Whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Geden, Matthew J., Romero, Selena E., Deshmukh, Mohanish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817838/
https://www.ncbi.nlm.nih.gov/pubmed/33473103
http://dx.doi.org/10.1038/s41419-020-03373-1
_version_ 1783638717713350656
author Geden, Matthew J.
Romero, Selena E.
Deshmukh, Mohanish
author_facet Geden, Matthew J.
Romero, Selena E.
Deshmukh, Mohanish
author_sort Geden, Matthew J.
collection PubMed
description While the consequences of nuclear DNA damage have been well studied, the exact consequences of acute and selective mitochondrial DNA (mtDNA) damage are less understood. DNA damaging chemotherapeutic drugs are known to activate p53-dependent apoptosis in response to sustained nuclear DNA damage. While it is recognized that whole-cell exposure to these drugs also damages mtDNA, the specific contribution of mtDNA damage to cellular degeneration is less clear. To examine this, we induced selective mtDNA damage in neuronal axons using microfluidic chambers that allow for the spatial and fluidic isolation of neuronal cell bodies (containing nucleus and mitochondria) from the axons (containing mitochondria). Exposure of the DNA damaging drug cisplatin selectively to only the axons induced mtDNA damage in axonal mitochondria, without nuclear damage. We found that this resulted in the selective degeneration of only the targeted axons that were exposed to DNA damage, where ROS was induced but mitochondria were not permeabilized. mtDNA damage-induced axon degeneration was not mediated by any of the three known axon degeneration pathways: apoptosis, axon pruning, and Wallerian degeneration, as Bax-deficiency, or Casp3-deficiency, or Sarm1-deficiency failed to protect the degenerating axons. Strikingly, p53, which is essential for degeneration after nuclear DNA damage, was also not required for degeneration induced with mtDNA damage. This was most evident when the p53-deficient neurons were globally exposed to cisplatin. While the cell bodies of p53-deficient neurons were protected from degeneration in this context, the axons farthest from the cell bodies still underwent degeneration. These results highlight how whole cell exposure to DNA damage activates two pathways of degeneration; a faster, p53-dependent apoptotic degeneration that is triggered in the cell bodies with nuclear DNA damage, and a slower, p53-independent degeneration that is induced with mtDNA damage.
format Online
Article
Text
id pubmed-7817838
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78178382021-01-28 p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration Geden, Matthew J. Romero, Selena E. Deshmukh, Mohanish Cell Death Dis Article While the consequences of nuclear DNA damage have been well studied, the exact consequences of acute and selective mitochondrial DNA (mtDNA) damage are less understood. DNA damaging chemotherapeutic drugs are known to activate p53-dependent apoptosis in response to sustained nuclear DNA damage. While it is recognized that whole-cell exposure to these drugs also damages mtDNA, the specific contribution of mtDNA damage to cellular degeneration is less clear. To examine this, we induced selective mtDNA damage in neuronal axons using microfluidic chambers that allow for the spatial and fluidic isolation of neuronal cell bodies (containing nucleus and mitochondria) from the axons (containing mitochondria). Exposure of the DNA damaging drug cisplatin selectively to only the axons induced mtDNA damage in axonal mitochondria, without nuclear damage. We found that this resulted in the selective degeneration of only the targeted axons that were exposed to DNA damage, where ROS was induced but mitochondria were not permeabilized. mtDNA damage-induced axon degeneration was not mediated by any of the three known axon degeneration pathways: apoptosis, axon pruning, and Wallerian degeneration, as Bax-deficiency, or Casp3-deficiency, or Sarm1-deficiency failed to protect the degenerating axons. Strikingly, p53, which is essential for degeneration after nuclear DNA damage, was also not required for degeneration induced with mtDNA damage. This was most evident when the p53-deficient neurons were globally exposed to cisplatin. While the cell bodies of p53-deficient neurons were protected from degeneration in this context, the axons farthest from the cell bodies still underwent degeneration. These results highlight how whole cell exposure to DNA damage activates two pathways of degeneration; a faster, p53-dependent apoptotic degeneration that is triggered in the cell bodies with nuclear DNA damage, and a slower, p53-independent degeneration that is induced with mtDNA damage. Nature Publishing Group UK 2021-01-20 /pmc/articles/PMC7817838/ /pubmed/33473103 http://dx.doi.org/10.1038/s41419-020-03373-1 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Geden, Matthew J.
Romero, Selena E.
Deshmukh, Mohanish
p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration
title p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration
title_full p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration
title_fullStr p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration
title_full_unstemmed p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration
title_short p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration
title_sort p53 is required for nuclear but not mitochondrial dna damage-induced degeneration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817838/
https://www.ncbi.nlm.nih.gov/pubmed/33473103
http://dx.doi.org/10.1038/s41419-020-03373-1
work_keys_str_mv AT gedenmatthewj p53isrequiredfornuclearbutnotmitochondrialdnadamageinduceddegeneration
AT romeroselenae p53isrequiredfornuclearbutnotmitochondrialdnadamageinduceddegeneration
AT deshmukhmohanish p53isrequiredfornuclearbutnotmitochondrialdnadamageinduceddegeneration